Search results for: Clinical Outcomes
Filter search results
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…DEA was applied to health outcomes and health expenditure data from 151 Primary Care Trusts (PCTs) (now Clinical Commissioning Groups) in England across seven clinical areas termed Programme Budget Categories…
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
1 September 2020
…level. Clinical Eligibility Criteria: (1) clinical eligibility criteria should complement the FDA label language, for example on standards for diagnosis. They should not go beyond reasonable use of clinical trial…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…and mortality. DEA was applied to health outcomes and health expenditure data from 151 Primary Care Trusts (PCTs) (now Clinical Commissioning Groups) in England across seven clinical areas termed Programme…
The Impact of New Medicines in the NHS: 70 Years of Innovation
1 August 2018
…interviewees and the strength of feeling about the magnitude of their positive impact in the NHS. Our evidence search identified a variety of benefits encompassing improvement in clinical outcomes, survival…
New publication: Using Patient Reported Outcomes to Improve Health Care
21 December 2015
…are a powerful way of measuring the outcomes from health care as viewed by patients themselves – providing important evidence from the patients’ perspective to complement traditional clinical measures. Using…
Does Relative Effectiveness Vary Across Europe?
9 August 2011
…reported results of relative efficacy from clinical trials, rather than the effectiveness of the treatment in actual clinical practice. A table of the studies is available in the presentation. The…
Cornerstones of ‘Fair’ Drug Coverage
30 September 2020
…or not drug prices reflect clinical and economic value. If they do, then plans should minimise non-clinical obstacles to access. Key recommendations include: Cost Sharing: (1) Patient cost sharing should…
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
23 August 2016
…Operational Research and Data Analytics, OHE. The panellists will give their perspectives on the influence of HTA scientific and outcomes advice on both the clinical development of new medicines and…
Evaluating novel antimicrobials within EU joint clinical assessments
16 April 2026
…research is required to solidify the selection of outcomes that could usefully be captured within JCA. Feasibility: The JCA’s PICO (Population, Intervention, Comparator, Outcomes) based assessment framework and patient-centred relative-effect mandate limits inclusion…